We are live on ! Find out more
TGI

TRV GP III Portfolio holdings

AUM $6.14M
1-Year Est. Return 45.44%
This Fund
S&P 500
This Quarter Est. Return
+78.62%
1 Year Est. Return
+45.44%
3 Year Est. Return
+169.98%
5 Year Est. Return
+802.39%
10 Year Est. Return
–
AUM
$204M
AUM Growth
+$84.8M
Cap. Flow
$0
Cap. Flow %
0%
Top 10 Hldgs %
100%
Holding
3
New
–
Increased
–
Reduced
–
Closed
–
Avg Time Held
4.3 quarters
Top 10 Avg Time Held
4.3 quarters
Top 20 Avg Time Held
4.3 quarters

Top Buys

No buys this quarter

Top Sells

No sells this quarter

Sector Composition

Rank Sector Weight
1 Healthcare 100%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow Held Since
VYGR icon
1
Voyager Therapeutics
VYGR
$151M
$122M 59.92%
6,391,176
– –
2017 Q4
5 quarters
NTGN
2
DELISTED
Neon Therapeutics, Inc. Common Stock
NTGN
$62.9M 30.82%
9,741,636
– –
2018 Q2
3 quarters
JNCE
3
DELISTED
Jounce Therapeutics, Inc. Common Stock
JNCE
$18.9M 9.26%
3,048,780
– –
2017 Q4
5 quarters

Similar funds

TRV GP III's Q1 2019 Portfolio in Review

As of Q1 2019, TRV GP III held 3 positions worth $204M, up 71% from $119M the previous quarter. Its ten largest holdings account for 100% of the portfolio.

Trading was light in Q1 2019: portfolio turnover was 0%. TRV GP III opened no new positions and made no exits, leaving the 3-position portfolio largely intact.

By sector, the portfolio is most concentrated in Healthcare at 100% of assets, unchanged from a quarter earlier.

  • TRV GP III's ten largest holdings make up 100% of its $204M portfolio in Q1 2019.
  • TRV GP III opened 0 new positions and closed 0 in Q1 2019.
  • TRV GP III's portfolio value rose 71% quarter-over-quarter to $204M.

Based on TRV GP III's 13F filing for Q1 2019, filed 3 May 2019.